EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSDCDG00000035349
Gene Symbol: KIF5B
3 Cross references
275 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSDCDG00000035506
Gene Symbol: LTA4H
3 Cross references
205 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSDCDG00000029966
Gene Symbol: LOC114788496
3 Cross references
166 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSDCDG00000021519
Gene Symbol: LOC114793734
3 Cross references
159 Possible Orthologues:

Leukotriene B4 Receptor 1-Like

Ensembl ID : ENSDCDG00000021516
Gene Symbol: LOC114793726
3 Cross references
143 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSDCDG00000029965
Gene Symbol: LTB4R2B
1 Cross references
166 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSDCDG00000025133
Gene Symbol: LOC114765219
3 Cross references
201 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSDCDG00000004700
Gene Symbol: KDM1A
3 Cross references
214 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSDCDG00000016948
Gene Symbol: LOC114786808
3 Cross references
210 Possible Orthologues:

Lysyl Oxidase Homolog 2b

Ensembl ID : ENSDCDG00000031378
Gene Symbol: LOC114799936
3 Cross references
213 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor 1-Like

Ensembl ID : ENSDCDG00000035663
Gene Symbol: LOC114791882
2 Cross references
201 Possible Orthologues:

Macrophage Colony-Stimulating Factor 1 Receptor-Like

Ensembl ID : ENSDCDG00000027085
Gene Symbol: LOC114767882
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).